4.7 Article

Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function

Related references

Note: Only part of the references are listed.
Article Cell Biology

Th17 and Treg cells function in SARS-CoV2 patients compared with healthy controls

Armin Sadeghi et al.

Summary: In COVID-19 patients, an increase in Th17 cells and decrease in Treg cells are associated with hyperinflammation and disease progression, with a higher inflammatory ratio observed in deceased patients compared to those who improved, indicating the critical role of inflammation in patient mortality.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Article Virology

Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: Clinical and laboratory characteristics

Saeid Taghiloo et al.

Summary: A novel human coronavirus, SARS-CoV-2, has been identified in China and spread globally, with studies showing a decrease in peripheral blood lymphocytes in most patients. This study in Iranian COVID-19 patients revealed decreased lymphocyte subsets compared to controls, particularly in severe cases. The increase in apoptosis of mononuclear cells in COVID-19 patients, especially in severe cases, suggests potential biomarkers for severity and prognosis.

JOURNAL OF MEDICAL VIROLOGY (2021)

Article Genetics & Heredity

Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19

Hannes Vietzen et al.

Summary: Host genetic variants, particularly KLRC2 deletion and HLA-E*0101, are significantly overrepresented in hospitalized COVID-19 patients, especially those requiring intensive care. These genetic variants are independent risk factors for severe COVID-19.

GENETICS IN MEDICINE (2021)

Review Immunology

The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease

Ritu Pasrija et al.

Summary: COVID-19 caused by SARS-CoV-2 virus leads to cytokines release syndrome (CRS) in critically ill patients, indicating a deregulated immune response and resulting in inflammation and lung injury in severe cases.

INTERNATIONAL IMMUNOPHARMACOLOGY (2021)

Article Cell Biology

Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients

Safa Tahmasebi et al.

Summary: The study showed that nanocurcumin significantly reduced the number of Th17 cells and levels of related inflammatory factors in both mild and severe COVID-19 patients, suggesting its potential as a modulatory compound for improving inflammatory conditions in patients.

JOURNAL OF CELLULAR PHYSIOLOGY (2021)

Review Oncology

COVID-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods

Faroogh Marofi et al.

Summary: SARS-CoV-2 emerged in Wuhan, China in late 2019 and was later named as 2019-nCoV. COVID-19 poses challenges to individuals with chronic health conditions and weakened immune systems. Early detection of carriers, especially asymptomatic individuals, with accurate diagnostic techniques is crucial in controlling the spread of the virus.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2021)

Article Cell Biology

The effects of oxygen-ozone therapy on regulatory T-cell responses in multiple sclerosis patients

Safa Tahmasebi et al.

Summary: Oxygen-ozone therapy can improve the condition of multiple sclerosis patients by increasing the frequency of Treg cells and the expression levels of related factors, decreasing the expression level of miR-146a, and significantly increasing the secretion levels of IL-10 and TGF-beta cytokines.

CELL BIOLOGY INTERNATIONAL (2021)

Review Biochemistry & Molecular Biology

Recent advances in antibody-based immunotherapy strategies for COVID-19

Abdolreza Esmaeilzadeh et al.

Summary: The emergence of the new SARS-CoV-2 virus causing COVID-19 has led to a global health crisis, with antibody-based therapies showing promising outcomes in accelerating treatment, preventing viral spread, and managing the pandemic.

JOURNAL OF CELLULAR BIOCHEMISTRY (2021)

Review Medicine, Research & Experimental

Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2

Mahnaz Ghaebi et al.

Summary: COVID-19 is a disease with unpredictable course and variable clinical presentations, with early management playing a crucial role in the outcome. Research suggests that immunological risk factors may influence disease progression and death in COVID-19.

LIFE SCIENCES (2021)

Article Virology

Natural killer cells and unconventional T cells in COVID-19

Niklas K. Bjorkstrom et al.

Summary: This article summarizes the responses of NK cells and unconventional T cells to SARS-CoV-2 infection, and discusses their roles in the pathogenesis of severe COVID-19. Understanding the early effector lymphocyte response in this novel disease will aid ongoing efforts in combating the pandemic.

CURRENT OPINION IN VIROLOGY (2021)

Review Cell Biology

Lymphopenia in COVID-19: Therapeutic opportunities

Nazanin Fathi et al.

CELL BIOLOGY INTERNATIONAL (2020)

Article Microbiology

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

Evangelos J. Giamarellos-Bourboulis et al.

CELL HOST & MICROBE (2020)

Editorial Material Immunology

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

Meijuan Zheng et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Review Biochemistry & Molecular Biology

The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system

Francesca Coperchini et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Review Infectious Diseases

Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence

Lisheng Wang et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Review Infectious Diseases

The SARS-CoV-2 outbreak: What we know

Di Wu et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Review Cell Biology

The outlook for diagnostic purposes of the 2019-novel coronavirus disease

Safa Tahmasebi et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2020)

Review Environmental Sciences

The First 75 Days of Novel Coronavirus (SARS-CoV-2) Outbreak: Recent Advances, Prevention, and Treatment

Yuxin Yan et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Review Pharmacology & Pharmacy

Nanocurcumin: A Promising Candidate for Therapeutic Applications

Adhimoolam Karthikeyan et al.

FRONTIERS IN PHARMACOLOGY (2020)

Review Immunology

Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies

Marisa Market et al.

FRONTIERS IN IMMUNOLOGY (2020)

Letter Infectious Diseases

Math and aftermath of COVID-19 pandemic and its interrelationship from the resilience perspective

Marko Curkovic et al.

JOURNAL OF INFECTION (2020)

Review Biochemistry & Molecular Biology

Natural Killer Cell Dysfunction and Its Role in COVID-19

Charmaine van Eeden et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Immunology

Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients

Hamed Valizadeh et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2020)

Article Clinical Neurology

Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients

Morteza Izadi et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)

Article Oncology

Acute lung injury in patients with COVID-19 infection

Liyang Li et al.

CLINICAL AND TRANSLATIONAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat

Jun Zheng

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Article Biochemistry & Molecular Biology

Nanocurcumin: A novel strategy in treating ankylosing spondylitis by modulating Th17 cells frequency and function

Mehrzad Hajialilo et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2019)

Article Cell Biology

The imbalance of Th17/Treg axis involved in the pathogenesis of preeclampsia

Shadi Eghbal-Fard et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Pharmacology & Pharmacy

Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators

Sanam Dolati et al.

PHARMACOLOGICAL REPORTS (2018)

Article Biotechnology & Applied Microbiology

Improved Anti-Cancer Effect of Curcumin on Breast Cancer Cells by Increasing the Activity of Natural Killer Cells

Hwan Hee Lee et al.

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2018)

Article Immunology

Immunomodulatory potential of nanocurcumin-based formulation

Mahendra Kumar Trivedi et al.

INFLAMMOPHARMACOLOGY (2017)

Review Immunology

Emerging insights into natural killer cells in human peripheral tissues

Niklas K. Bjorkstrom et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Review Food Science & Technology

The beneficial role of curcumin on inflammation; diabetes and neurodegenerative disease: A recent update

Shatadal Ghosh et al.

FOOD AND CHEMICAL TOXICOLOGY (2015)

Review Pharmacology & Pharmacy

Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials

Subash C. Gupta et al.

AAPS JOURNAL (2013)

Review Pharmacology & Pharmacy

Nanocurcumin: A Promising Therapeutic Advancement over Native Curcumin

Gagan Flora et al.

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2013)

Article Medicine, Research & Experimental

Sustained Wound Healing Activity of Curcumin Loaded Oleic Acid Based Polymeric Bandage in a Rat Model

Chandana Mohanty et al.

MOLECULAR PHARMACEUTICS (2012)

Review Immunology

New insights for C5a and C5a receptors in sepsis

Chunguang Yan et al.

FRONTIERS IN IMMUNOLOGY (2012)

Article Immunology

C5a Regulates NKT and NK Cell Functions in Sepsis

Michael E. Fusakio et al.

JOURNAL OF IMMUNOLOGY (2011)

Article Immunology

Immunomodulatory effects of curcumin

VS Yadav et al.

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2005)

Article Immunology

CD56+dim and CD56+bright cell activation and apoptosis in hepatitis C virus infection

AW Lin et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)